Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

SELL
$254.9 - $283.59 $281,409 - $313,083
-1,104 Reduced 3.97%
26,715 $6.91 Million
Q2 2023

Aug 04, 2023

BUY
$238.39 - $265.32 $5,959 - $6,633
25 Added 0.09%
27,819 $7.34 Million
Q1 2023

Apr 21, 2023

BUY
$229.71 - $259.35 $14,012 - $15,820
61 Added 0.22%
27,794 $6.88 Million
Q4 2022

Jan 27, 2023

SELL
$218.29 - $256.91 $227,021 - $267,186
-1,040 Reduced 3.61%
27,733 $7.05 Million
Q3 2022

Oct 31, 2022

SELL
$51.03 - $264.23 $5,256 - $27,215
-103 Reduced 0.36%
28,773 $6.41 Million
Q2 2022

Aug 11, 2022

SELL
$234.74 - $275.42 $11,737 - $13,771
-50 Reduced 0.17%
28,876 $7.12 Million
Q1 2022

May 02, 2022

SELL
$243.64 - $270.48 $71,386 - $79,250
-293 Reduced 1.0%
28,926 $7.69 Million
Q4 2021

Feb 04, 2022

SELL
$230.08 - $250.94 $96,633 - $105,394
-420 Reduced 1.42%
29,219 $7.35 Million
Q3 2021

Oct 22, 2021

BUY
$232.72 - $256.47 $849,428 - $936,115
3,650 Added 14.04%
29,639 $7.29 Million
Q2 2021

Aug 02, 2021

SELL
$232.65 - $254.58 $141,683 - $155,039
-609 Reduced 2.29%
25,989 $6.32 Million
Q4 2020

Jan 27, 2021

BUY
$221.92 - $245.94 $116,508 - $129,118
525 Added 2.01%
26,598 $6.66 Million
Q3 2020

Oct 23, 2020

SELL
$215.77 - $276.76 $4,315 - $5,535
-20 Reduced 0.08%
26,073 $6.07 Million
Q1 2020

Apr 27, 2020

BUY
$195.69 - $279.01 $14,676 - $20,925
75 Added 0.29%
26,093 $6 Million
Q4 2018

Jan 18, 2019

SELL
$204.73 - $257.93 $5,118 - $6,448
-25 Reduced 0.1%
26,018 $5.86 Million
Q1 2018

May 04, 2018

SELL
$205.46 - $240.27 $51,365 - $60,067
-250 Reduced 0.95%
26,043 $5.64 Million
Q4 2017

Jan 29, 2018

SELL
$189.0 - $222.64 $670,950 - $790,372
-3,550 Reduced 11.9%
26,293 $5.63 Million
Q3 2017

Nov 02, 2017

BUY
$186.89 - $198.9 $5.58 Million - $5.94 Million
29,843
29,843 $5.85 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Thomas Story & Son LLC Portfolio

Follow Thomas Story & Son LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomas Story & Son LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thomas Story & Son LLC with notifications on news.